Icon

NESINA (nda022271)- (EQ 6.25MG BASE,EQ 12.5MG BASE,EQ 25MG BASE)

ALOGLIPTIN BENZOATE TAKEDA PHARMS USA
EQ 6.25MG BASE,EQ 12.5MG BASE,EQ 25MG BASE
Yes No
2029-Jun-16 2018-Jan-25
None None
None No
NESINA is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
0 4 0
Total Other Developers 1
Drugs with Suitability No
EQ 6.25MG BASE ** ** - - -
EQ 12.5MG BASE ** ** - - -
EQ 25MG BASE ** ** Down - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.